The HinduHealth
Regulator warns of action over cancer drug prices
The National Pharmaceutical Pricing Authority has told state drug controllers to closely monitor prices for 137 anti-cancer medicines. Companies that fail to follow the new prices could face action, though the regulator did not specify possible penalties.
This card is an AI-assisted summary of reporting published by The Hindu. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.